Market Overview

UPDATE: JP Morgan Raises PT to $50 on Cintas; Revenue Momentum Offsets EPS Miss

Related CTAS
Top 4 NASDAQ Stocks In The Business Services Industry With The Highest Revenue
UPDATE: Bank Of America Reiterates On Cintas On Positive 4Q Trends, Muted FY15 Outlook

JP Morgan maintained Cintas (NASDAQ: CTAS) with an Overweight rating and raised the price target from $47.00 to $50.00.

JP Morgan analyst Andrew C. Steinerman commented, "Thursday evening, Cintas reported 3QF13 (Feb) revenues of $1,076mln, ~2% above our estimate, as organic same-day basis (SDB) revenue growth rose to 6.9% y/y (from 3.4% y/y in 2QF13 (Nov)). 3QF13 EPS was $0.60, slightly below our estimate of $0.63. … The new healthcare regulations represent a prospective CY2014 margin headwind, but in a healthy economy CTAS should have high enough top-line growth and operating levers to overcome this headwind, in our view."

Cintas closed at $45.93 on Tuesday.

Latest Ratings for CTAS

Sep 2014JefferiesMaintainsBuy
Jul 2014JP MorganMaintainsOverweight
Jan 2014BarclaysMaintainsEqual-weight

View More Analyst Ratings for CTAS
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Analyst Ratings


Related Articles (CTAS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters